Stelvio Oncology

Stelvio Oncology utilizes an image based method of epigenetic markers to develop predictive diagnostics and novel therapeutics for cancer. Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Our team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics. The biggest problem in cancer remains drug resistance and loss of response to treatment which ultimately leads to no viable alternatives for patients. We are targeting cancer stem cell fates which have resistance mechanisms. Our team is focusing on developing a personalized approach to glioblastoma treatment.